Combination Therapy Enhances Treatment Outcomes in Advanced Triple-Negative Breast Cancer
A groundbreaking study emerging from the Icahn School of Medicine at Mount Sinai illuminates a promising new avenue in the ...
A groundbreaking study emerging from the Icahn School of Medicine at Mount Sinai illuminates a promising new avenue in the ...
In a promising advancement for breast cancer therapeutics, researchers have uncovered a potent synergy between Tanshinone IIA, a bioactive compound ...
A groundbreaking randomized phase II clinical trial, designated the MIRINAE trial (KCSG-BR18-21), has recently emerged from South Korea investigating innovative ...
In a groundbreaking study published recently in Nature Communications, researchers have unveiled a novel immunomodulatory strategy that promises to revolutionize ...
In the dynamic landscape of cancer research, the quest for innovative treatment avenues remains paramount, particularly in the context of ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine